Application no. and date | 04719030.1 (espacenet) (Federated) (European Patent Register), 20040310 | Patent/reg. no. and date | DK/EP 1608407, 20060830 | Publication date | 20051228 | Priority no. and date | US 456325 P, 20030320 | EP pub. no. and date |
EP 1608407 20051228 | Effective date | | Applicant/owner | Pharmacia Corporation, 700 Chesterfield Parkway West
Chesterfield, MO 63017-1732, US | Applicant ref. no. | P80601665DK00E | Inventor | BRITTEN, Nancy, J.
Pfizer Global Res, and Dev., 700 Chesterfield Parkway West
Chesterfield, MO 63017-1732, US, BURNS, John, W.
Pfizer Global Res. and Dev., 700 Chesterfield Parkway West
Chesterfield, MO 63017-1732, US, HALLBERG, John, W.
Pfizer Global Res. and Dev., 700 Chesterfield Parkway West
Chesterfield, MO 63017-1732, US, WALDRON, Niki, A.
Pfizer Global Res. and Dev., 700 Chesterfield Parkway West
Chesterfield, MO 63017-1732, US, WATTS, Jeffrey, L.
Pfizer Global Res. and Dev., 700 Chesterfield Parkway West
Chesterfield, MO 63017-1732, US | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | Opponent | | IPC Class | A61K 45/06 (2006.01) , A61K 47/44 (2006.01) | Title | Dispergébar formulering af et antiinflammatorisk middel | Int. application no. | IB2004000826 | Int. publication no. | WO2004082588 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|